Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC

INTRODUCTION: Whereas tumor biopsy is the reference standard for genomic profiling of advanced NSCLC, there are now multiple assays approved by the Food and Drug Administration for liquid biopsy testing of circulating tumor DNA. Here, we study the incremental value that liquid biopsy comprehensive g...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzberg, Lee S., Li, Gerald, Tolba, Khaled, Bourla, Ariel B., Schulze, Katja, Gadgil, Rujuta, Fine, Alexander, Lofgren, Katherine T., Graf, Ryon P., Oxnard, Geoffrey R., Daniel, Davey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460153/
https://www.ncbi.nlm.nih.gov/pubmed/36089920
http://dx.doi.org/10.1016/j.jtocrr.2022.100386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460153/
https://www.ncbi.nlm.nih.gov/pubmed/36089920
http://dx.doi.org/10.1016/j.jtocrr.2022.100386

Ejemplares similares